Healthcare Press Releases

Fearless Girl

With this award we acknowledge the place she has won in the minds and hearts of females everywhere.

NEW YORK, NEW YORK, USA, September 19, 2018 /EINPresswire.com/ — In recognition of the stunning impact she has had around the world, Fearless Girl will be honored at M2W®-The Marketing to Women Conference, with the ‘This Woman Means Business!” Award. This year the award has been renamed by adding the word “Young” to recognize her forever young and inspiring presence for generations to come.

Lizzie Wilson, part of the creative team at ad agency McCann New York that created the Fearless Girl campaign in partnership with client State Street Global Advisers, will accept the award on behalf of the team. M2W® is an executive learning event that teaches brand marketers how to build more business with women, who account for $7 trillion annual consumer spending in the US, and over $20 trillion globally. M2W® will be held Oct. 3 & 4, 2018, New York City.

“The Fearless Girl is an international treasure,” according to Nan McCann, M2W® producer. “She stands unwavering on Wall Street and is perpetually fearless. With this award we acknowledge the place she has won in the minds and hearts of females everywhere. She is today and always, a Young Woman Who Means Business, and it is our good fortune to have her in our midst.”

“Every year the M2W® This Woman Means Business! award is presented to a proven leader… a woman of inspiration…an innovator and visionary…someone who produces positive results, while energizing and engaging those around her,” McCann explained. “By example she champions women in the workplace, in the marketplace, and in the world. She is a reminder to all that when doors are open to women, they will be a transforming economic & cultural force…and that every worthy enterprise will thrive by engaging women like her who mean business.”

The Fearless Girl has won 4 Grand Prix at the Cannes Lions Festival of Creativity, and top awards at D&AD, D&AD Impact, Clio, Cresta, London International, One Show, New York Festivals, AICP Next and Effie Awards. With Fearless Girl serving as a powerful symbol to help amplify their message, State Street Global Advisors has made board diversity a key focus of their corporate governance policies, motivating over 150 public companies around the globe to add a woman to their previously all-male boards.

“M2W®’s audience,” McCann continued, “is comprised of powerful and influential marketing execs who control hundreds of millions of brand advertising and communications dollars. And the Fearless Girl embodies the qualities I think they all hope for and value in corporate, non-profit and civic marketing efforts and governance. I’m sure the award will be one of this year’s highlights.”

“M2W® is annually attended by Fortune 1000 senior brand marketing executives and their agencies. The audience typically includes companies as diverse as Harley-Davidson, Bayer, Aetna, ESPN, Kraft Foods, Ford, GM, Johnson & Johnson, Kelloggs, Diageo, Walgreens, Wells Fargo, NBA, WebMD, Burton, L’Oreal, ConAgra and Whirlpool. “They attend,” McCann said, “because they recognize the brand-critical importance of engaging women. Their purchasing power is critical to the success of almost every brand in every major consumer category. Women are today’s power consumers.”

M2W® supports Save The Children. M2W® is presented by Google and supported by Associate Sponsors: AARP and McCann Worldgroup, Showcase Sponsors include: Incite & Ask Patty. M2W®’s video resource is Snippies.

For complete conference schedule and information visit: www.m2w.biz or call 860.724.2649 x13. M2W® is produced by PME® Enterprises LLC, 912 Silas Deane Highway, Suite 101, Wethersfield, CT 06109. PME® is a sales and marketing agency with a special emphasis on events.

Nanci McCann
PME Enterprises LLC
8607242649
email us here

Source: EIN Presswire

M2Moms® – The Marketing to Moms Conference, Oct. 2 & 3, NYC

Over 35 Speakers From Every Category Help Brands Reach Moms

NEW YORK, NEW YORK, USA, September 19, 2018 /EINPresswire.com/ — Over 35 speakers on topics ranging from experiential marketing and location-based mom tech, to the latest research on moms and social, digital and mobile communications techniques will be participating in the 14th Annual M2Moms® – The Marketing to Moms Conference, Oct. 2 & 3, NYC. According to M2Moms® producer, Nan McCann, “There’s nothing else like it. The presentations are designed to help brand marketing executives and their agencies improve their overall business results with today’s moms.”

“Today’s moms, especially millennial moms, are really different than previous generations of moms,” McCann said. “For example, 61% of first-time births to millennial moms are to single women. 65% of moms with children under 6 work. 39% of new moms change an average of 5.5 diapers per day. 43% of new moms do an average of 4 loads of laundry per week. 43% of new moms sleep only 5.5 hours per day. When you consider the constant stress and time challenges facing today’s moms, brand marketing messages need to be spot-on and delivered at the right time on the right channel. “

Speakers include: Paul Siefken, Fred Rogers Productions; Enna Allen, Simon Malls; Mandy Arioto, MOPS; Amy Przywara, Sylvan Learning; Patty David, AARP; Elle Walker & Meg Resnikoff, What’s Up Moms; Kurt Workman, Owlet Baby Monitors; Skyler Mattson, WongDoody & June Cleaver is Dead; Michelle Poris, Smarty Pants; Agata Reyes, Destination Maternity; Rachel Curry, Volvo USA. For a full list of speakers go to www.m2moms.com/speakers

“M2Moms® is definitely a ‘don’t miss’ for every exec who markets to moms,” McCann added. “It’s packed with sessions structured to help brands improve and evolve their marketing to moms efforts in a rapidly changing communications environment.”

“That’s why every year M2Moms® is attended by a comprehensive and diverse list of brands including Microsoft, Johnson & Johnson, Evenflo, IKEA, Abbott Nutritionals, GM, Allstate, Heinz, Symantec, Hasbro, Procter & Gamble, Wyeth and Coca-Cola,” according to McCann. “M2Moms® attendance typically sells out.”

The 2018 M2Moms® proudly supports Save the Children. Sponsors include: Presenting Sponsor: Google; Associate Sponsors: AARP, What’s Up Moms, WongDoody; Showcase Sponsors: GfK, Fosina Marketing Group, Sylvan Learning, MOPS International, Famifi, Destination Maternity, BabyPage, Ask Patty, Strottman, Hillside & Knox, Foursquare, PlayWell TEKnologies, Response Media, GreyHealth Group, Raising Dragons, Marketing to Mums, Smarty Pants, Kids II, The Motherhood and Simon Property Group. Media Sponsor: MomTrends Media. Video Content Resource Sponsor: Snippies.

For M2Moms® information: www.m2moms.com or 860.724.2649 x13. M2Moms® is produced by PME® Enterprises LLC, 912 Silas Deane Hwy., Suite 101, Wethersfield, CT 06109.

Nanci McCann
PME Enterprises LLC
8607242649
email us here

Source: EIN Presswire

Zibtek launches its new office in Bengaluru. They are planning to hire the best talent to assist them in various streams of operation.

BANGALORE, KARNATAKA, INDIA, September 19, 2018 /EINPresswire.com/ — Zibtek opened a new office in Bengaluru, India, on April 4, 2018. Their operations in India first started in Pune in 2009. Zibtek has its presence in India for almost nine years now. With the help of Raja Ganabathi, one of the partners of Zibtek, they worked hard to establish the office here in Bengaluru.

Bengaluru is larger than Pune when it comes to the total population and the sophistication of the IT industry. While Pune has almost 2.4 million people, Bengaluru has nearly 13 million people living in the city today. It is a city rich in resources, especially when it comes to finding high-quality labor. No other city in India comes close when it comes to talent in the tech industry.

The management of Zibtek has hired people to support various operations including sales, marketing, and human resources. They have plans to expand their business, and this new location will help them move toward achieving that goal.

The ultimate goal of Zibtek in opening the branch in Bengaluru is to start Business Process Outsourcing (BPO) services. With focused marketing and development on BPO services, they will soon have full-fledged operations.

About Zibtek: Zibtek is one of the world’s leading software, web, and mobile development companies. They also provide various other services such as digital marketing, design, and BPO. They have a growing base of satisfied customers because they work efficiently to deliver the best product or service in a highly competitive global, digital economy.

Address:

Zibtek Pvt Ltd
NO.651-5M, RAIS PINNACLE, 2nd Floor,
OMBR Layout, Banaswadi,
Bangalore, 560016. India.
https://www.zibtek.com

Jonas Gihone Akula
Zibtek
7019519976
email us here

Source: EIN Presswire

LONDON, GREATER LONDON, UK, September 19, 2018 /EINPresswire.com/ — Organs-on-chips (OOCs) are a revolutionary new technology for drug development but their full potential will only be realized when regulatory approval is given for using the data generated from OOCs in the pharmaceutical industry's regulatory submissions, The Business Research Company's report Organ-On-Chip Global Market Opportunities And Strategies To 2021 explains.

Organs-on-chips are microfluidic 3D cell culture devices that closely mimic the key physiological functions of body organs. Most chips are not designed to biomimic an entire organ, but simulate the physiology of a single functional unit of an organ system. They have resulted from scientific advances in cell biology, microfabrication and microfluidics which allow the emulation of the human micro environment in vitro. This unique feature of OOCs is made possible by integrating biology with advanced engineering technologies. Human organs-on-chips (OOCs) are miniaturized versions of lungs, livers, kidneys, heart, brain, intestines and other vital human organs embedded in a chip.

Download a sample of the report at https://www.thebusinessresearchcompany.com/sample.aspx?id=805&type=smp

OOC technology offers a less time-consuming and more cost-effective way to test for the efficacy and toxicity of new drugs, foods, cosmetics and dietary supplements. Overall, they have the potential to break an impasse in in-vitro discovery and development in these fields. However, at present, owing to the neoteric nature of OOC technology no regulations exist for the use of OOCs in drug testing and OOC-based evidence is not accepted in drug approval processes. In the long run, however, OOC companies are expected to get approval from regulatory bodies such as the US FDA and Europe’s EMA for their products. This will help pharmaceutical companies to use the data generated from OOCs in their research and regulatory submissions.

The Business Research Company (TBRC) is optimistic about the prospects for this technology, because, as a senior sales and marketing manager from Novartis put it, “The value proposition of OOCs for pharmaceutical companies is very strong in terms of reducing clinical failure rates and reliance on animal testing”. TBRC's forecast is for the market's growth rate to accelerate.

Organ-on-Chips Global Market Opportunities And Strategies To 2022 is one of a series of new industry reports from The Business Research Company that identify opportunities and explain strategies in a range of industries, provide a market overview, analysis and forecasts of market size and industry statistics, market growth rates, market trends, market drivers, market restraints, market revenues, market shares and company profiles of the leading competitors in over 300 industry reports, covering over 2400 market segments and 60 geographies. The industry reports draw on 150,000 datasets. Extensive secondary research is augmented with exclusive insights and quotations from industry leaders obtained through interviews. Market analysis and forecasts are provided by a highly experienced and expert team of analysts and modellers.

Request for Discount at https://www.thebusinessresearchcompany.com/sample.aspx?id=805&type=discount

Where to Learn More
Read Organ-on-Chip (OOC) Global Market Opportunities and Strategies To 2022 from The Business Research Company for information on the following:

Markets Covered: organ-on-chip industry, lung-on-chip industry, heart-on-chip industry, liver-on-chip industry, intestine-on-chip industry, kidney-on-chip industry, human-on-chip industry, human disease and tissue models, and microfluidics
Companies Mentioned: CN Bio Innovations, Emulate Inc., TissUse GmbH, Mimetas, HµREL Corporation (HµREL), Nortis, InSphero, Tara Biosystems, and AxoSim Techologies LLC
Regions: North America, Europe, Asia and Rest Of World (ROW)
Time series: Historic and Forecast 2011 to 2021
Data: Market value in $ Million
Number of Figures: 66
Number of Tables: 78
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.

Download Complete Table of Contents at https://www.thebusinessresearchcompany.com/sample.aspx?id=805&type=toc

Interested To Know More? Here is a list of reports from The Business Research Company similar to Organ-On-Chip Global Market Opportunities And Strategies To 2021
Biologics Global Market Opportunities And Strategies To 2021
Blood Glucose Test Strips Global Market Opportunities And Strategies To 2021 (https://www.thebusinessresearchcompany.com/report/blood-glucose-test-strips-global-market-opportunities-and-strategies-to-2021)
Healthcare Services Global Market Report 2018 (https://www.thebusinessresearchcompany.com/report/healthcare-services-global-market-report-2018 )

About The Business Research Company
The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has research professionals at its office in the UK, India, and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology. The Business Research Company’s management have more than 20 years of varied business research experience. They have delivered hundreds of research projects to the senior management of some of the world’s largest organizations. The Business Research Company’s Consultants have master’s qualifications from top institutes and include MBAs, MSCs, CFAs and CAs. The Business Research Company’s Consultants gain training and qualifications from the Market Research Society and are trained in advanced research practices, techniques, and ethics.

Oliver Guirdham
The Business Research Company
+44 207 1930 708
email us here

Source: EIN Presswire

LONDON, GREATER LONDON, UK, September 19, 2018 /EINPresswire.com/ — The global healthcare predictive analytics industry will see its revenues almost triple between 2018 and 2022, a new report from The Business Research Company, Healthcare Analytics Global Market Opportunities And Strategies To 2022 has shown. the healthcare predictive analytics industry provides the tools that use past unstructured data to predict future actions through a customer/market perspective. The healthcare prescriptive analytics industry will also see its sales nearly triple, but this market is much smaller than the healthcare predictive analytics market in 2018 and so will put on less value in dollar terms by 2022. The healthcare prescriptive analytics industry supplies the decision modelling systems for the healthcare industry that include examination of past and current patient data to recommend a course of action. The healthcare descriptive analytics industry is also achieving rapid growth, though at a rate nearly 10 percentage points below the other two segments. The healthcare descriptive analytics industry provides the systematic quantitative gathering and transformation of data that includes hospitalization summaries, frequency of disease cases and length of patient stays in hospital.

The particular importance of healthcare predictive analytics lies in the availability of large volumes of data, and the potential of healthcare predictive analytics for improving outcomes through early detection. Predictive measurement can help with early diagnosis of diseases that will reduce suffering and healthcare costs in the future.

Download a sample of the report at https://www.thebusinessresearchcompany.com/sample.aspx?id=802&type=smp

An alternative way of segmenting the healthcare analytics industry is into the healthcare clinical data analytics industry, the healthcare administrative and operational analysis industry and the healthcare financial analytics industry. The healthcare financial analytics industry is the largest of these segments and will continue to be so for years to come.

Healthcare Analytics Global Market Opportunities And Strategies To 2022 is one of a series of new industry reports from The Business Research Company that identify opportunities and explain strategies in a range of industries, provide a market overview, analysis and forecasts of market size and industry statistics, market growth rates, market trends, market drivers, market restraints, market revenues, market shares and company profiles of the leading competitors in over 300 industry reports, covering over 2400 market segments and 60 geographies. The industry reports draw on 150,000 datasets. Extensive secondary research is augmented with exclusive insights and quotations from industry leaders obtained through interviews. Market analysis and forecasts are provided by a highly experienced and expert team of analysts and modellers.

Request for Discount at https://www.thebusinessresearchcompany.com/sample.aspx?id=802&type=discount

Where To Learn More
Read Healthcare Analytics Global Market Opportunities And Strategies To 2022 from The Business Research Company for information on the following:

Markets Covered: Healthcare data analytics market, healthcare descriptive analytics market, healthcare predictive analytics market, healthcare prescriptive analytics market, healthcare financial data analytics market, healthcare administrative and operational data analytics market, healthcare clinical data analytics market, and others
Data Segmentations: Healthcare analytics global and regional total, and by technology and application segmentation – descriptive analytics, predictive analytics, prescriptive analytics, healthcare financial data analytics, administrative and operational data analytics, clinical data analytics, and others 2014-22 market size and growth rates.
Healthcare Analytics Organizations Covered: IBM (International Business Machines Corporation), Oracle Corporation, McKesson Corporation, Truven Health Analytics (Private Subsidiary), Cerner Corporation.
Regions: North America, Europe, Asia Pacific, ROW (Rest of world)
Time Series: 2014-16 actuals, 2017 estimates, 2018-22 forecasts.
Other Information And Analyses: Porters five forces analysis for healthcare analytics global market, value chain analysis, market drivers, market challenges, company overview, business strategy, financial overview, products and services, recent developments, key M&A and strategic partnerships
Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.
Number of Figures: 20
Number of Tables: 29

Download Complete Table of Contents at https://www.thebusinessresearchcompany.com/sample.aspx?id=802&type=toc

Interested to know more? Here is a list of reports from The Business Research Company similar to Healthcare Analytics Global Market Opportunities And Strategies To 2022:
Healthcare Services Global Market Report 2018
Information Services Global Market Report 2018 (https://www.thebusinessresearchcompany.com/report/information-services-global-market-report-2018)

About The Business Research Company
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Oliver Guirdham
The Business Research Company
+44 207 1930 708
email us here

Source: EIN Presswire

The headquarters for CCHR Florida are located in downtown Clearwater

Over a million children under the age of six are currently on psychiatric drugs in America

The Florida chapter of the Citizens Commission on Human Rights (CCHR), is hosting a seminar on ADHD with Child Education Specialist, Sharon Hillestad.

CLEARWATER, FLORIDA, UNITED STATES, September 19, 2018 /EINPresswire.com/ — Prompted by new information on the use of psychotropic drugs to treat childhood difficulties in school, the Florida chapter of the Citizens Commission on Human Rights (CCHR), is hosting a seminar on ADHD with Child Education Specialist, Sharon Hillestad.

During the seminar Ms. Hillestad will cover the tests used to diagnose ADHD, alternative treatment options, the signs of a child who isn’t doing well in school and how all of this can be addressed with healthy, safe methods.

Currently there are approximately 1.8 million children between the ages of 12-17 in the United States who are taking prescription psychotropic drugs, largely to treat difficulties with study.

One of the common psychostimulants used to treat ADHD, methylphenidate is a Schedule II drug, meaning the U.S. Drug Enforcement Administration (DEA) has classified it as having a high potential for abuse. Additionally, the DEA warns that methylphenidate produces many of the same effects as cocaine. Psychotic episodes and severe psychological addiction have all been associated with methylphenidate abuse. The side effects for Ritalin (methylphenidate hcl), include nervousness, agitation, and anxiety as the top 3 listed effects, as well as psychosis. [1] [2]

For more information or to find out when the next educational briefing will be held, please call CCHR at (727) 442-8820 or visit the center at 109 N. Fort Harrison Ave, Clearwater, Florida.

About CCHR: Initially established by the Church of Scientology and renowned psychiatrist Dr. Thomas Szasz in 1969, CCHR’s mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections. L. Ron Hubbard, founder of Scientology, first brought psychiatric imprisonment to wide public notice: “Thousands and thousands are seized without process of law, every week, over the ‘free world’ tortured, castrated, killed. All in the name of ‘mental health,’” he wrote in March 1969. For more information visit, www.cchrflorida.org

Sources:
[1] CCHR Alerts Parents About New Federal Statistics Showing Rates of Youth Overdose Deaths on 'ADHD' Stimulants and Benzodiazepines Are Greater Than on Cocaine https://www.prnewswire.com/news-releases/cchr-alerts-parents-about-new-federal-statistics-showing-rates-of-youth-overdose-deaths-on-adhd-stimulants-and-benzodiazepines-are-greater-than-on-cocaine-300507566.html
[2] Ritalin Side Effects Center
https://www.rxlist.com/ritalin-side-effects-drug-center.htm

Diane Stein
Citizens Commission on Human Rights of Florida
(727) 422-8820
email us here

ADHD is a Label, Not a Disease

Source: EIN Presswire

NEW YORK, NEW YORK, USA, September 19, 2018 /EINPresswire.com/ — The Montana Mesothelioma Victims Center says, "We are passionate about assisting a power or energy worker with mesothelioma in Montana because we know with the help of some of the nation's most skilled and capable mesothelioma attorneys, these individuals really can get a much better financial compensation settlement.

"We specialize in assisting oil refinery, oil production workers and power plant workers with mesothelioma because we want these types of people to get the best possible mesothelioma financial compensation results. We are urging an individual who now has mesothelioma because of exposure at an oil refinery, oil/gas production field or at a power plant in Montana to call us anytime at 800-714-0303 for on-the-spot access to some of the nation's most experienced and skilled mesothelioma attorneys.

"You are going to need some of the nation's very best mesothelioma lawyers if you want to receive the best possible mesothelioma compensation as we would like to discuss anytime at 800-714-0303. We also want to emphasize the mesothelioma attorneys we suggest will come to you in Montana for a no obligation visit to help determine what a mesothelioma compensation settlement package might be worth." http://Montana.MesotheliomaVictimsCenter.Com

The Montana Mesothelioma Victims Center's unsurpassed free services are available throughout Montana in every community including Billings, Missoula, Great Falls, Bozeman, Butte, Helena, Kalispell, Havre, Anaconda, or Miles City. http://Montana.MesotheliomaVictimsCenter.Com

For the best possible treatment options in Montana we strongly recommend the following heath care facilities with the offer to help a diagnosed victim, or their family get to the right physicians at each hospital.

* Providence Health Services Western Montana: https://montana.providence.org/locations-directory/m/montana-cancer-center
* The Billings Clinic: https://www.billingsclinic.com/services-specialties/cancer/.

High risk occupations for exposure to asbestos in Montana include the US Navy, Malmstrom Air Force Base workers, 341st Missile Wing workers, miners, oil refinery workers, smelter workers, pulp and paper mill workers, welders, plumbers, machinists, mechanics, insulators, construction workers, railroad workers and or former residents of Libby, Montana. http://Montana.MesotheliomaVictimsCenter.Com

The Mesothelioma Victims Center is a national advocate 100% focused in on doing everything possible to ensure people with mesothelioma in Montana and every state receive the best possible financial compensation settlement. The group offers on the spot access to some of the nation’s most skilled and experienced mesothelioma attorneys because to receive the very best possible financial compensation a diagnosed person must be represented by the most capable mesothelioma lawyers in the United States as they would like to discuss anytime at 800-714-0303. http://MesotheliomaVictimsCenter.Com

For more information about mesothelioma please refer to the National Institutes of Health's web site related to this rare form of cancer: https://www.cancer.gov/types/mesothelioma

Michael Thomas
Montana Mesothelioma Victims Center
800-714-0303
email us here

Source: EIN Presswire

LAS VEGAS, NEVADA, UNITED STATES, September 18, 2018 /EINPresswire.com/ — For most people who want to look like a thin or buff celebrity they will tend to emulate their diet and lifestyle hoping to capture their same body type and image. When one fad diet doesn’t work they try another and another, generally to no avail. What is the ideal way to become our healthiest, most authentic selves where we can finally accomplish our best selves inside and out?

Glen is a Speaker, Health & Wellness Coach, Clinical Social Worker, and Author of “Living in Total Health.”

“Living in Total Health” is about each individual’s unique path to their optimal level of health,” says Glen. “Everyone should take into account their own personal situation including lifestyle, finances, needs, and recognize what works the best for them on an emotional, mental, spiritual, and physical level. People tend to focus way too much on diet and exercise but the fact is we are comprised of much more than our size and metabolism Total Health integrates the whole person.”

Glen’s straight forward, no nonsense approach encourages clients to authentically take a new perspective on connecting to their core rather than their ego. She affirms how every choice has a positive, negative, or neutral outcome. For instance if a person has diabetes in their family and that person chooses to consume excess sugar, then their choices are leading them to a potentially negative consequence—diabetes and kidney disease for examples. Through her expert coaching, Glen methodically and skillfully seeks out her client’s motivations and goals then provides much needed information, guidance, and clarity.

“When a person is “aware” of what they are doing, thinking and feeling then they are better able to accept the consequences,” says Glen. “Making conscious choices places you in a more powerful position than making them “blindly.”

Glen’s insightful message includes how people must be sincerely open to new ideas and genuinely accept responsible for their own decisions.

“When people aren’t proactive in their lives they leave it up to chance and then get upset when things don’t work out in their favor,” says Glen. “Living in total health requires a level of awareness that provides the learning opportunities for overall improvement.”

“When people simply focus on diet and exercise ignoring those other components of who they are they are limiting themselves. By living in total health we become aware of the emotional, mental, physical, and spiritual parts of how we live and not just what our bodies look like”

According to Glen, people are not aware of who they are because they are living from their ego and not their core.

“Everything we need is within and connecting with our personal truth provides the insights that lead to total health and well-being.” says Glen. “Since health is more than just physical, our mental, emotional, and spiritual selves must unequivocally be addressed in any health program. When we are linked with our core the truth of who we really are has a powerful peaceful flow that helps us evolve and progress. Live consciously and you will be find joy and be connected to your true selves.”

CUTV news will feature Glen Alex in an interview with Doug Llewelyn Wednesday September 19th at 10 a.m. EST.

Listen to the show on BlogTalkRadio.

If you have any questions for our guest, please call (347) 996-3389.

For more information on Glen Alex please visit www.livingintotalhealth.com

Author: Beatrice Maria Centeno

Lou Ceparano
CUTV News
(631) 850-3314
email us here

Source: EIN Presswire

Molecular Biologist’s Discovery Proven to Reverse the Aging Process – RevolutionaryTAM-818 molecule is rocking the multi-billion-dollar anti-aging industry.

RENO, NEVADA, UNITED STATES, September 18, 2018 /EINPresswire.com/ — Internationally-acclaimed molecular biologist Dr. Bill Andrews, Ph.D.—founder of Sierra Sciences in Reno, Nevada—recently introduced the TAM-818 molecule, his latest invention that is rocking the multi-billion-dollar worldwide anti-aging industry. It has been proven in extensive laboratory testing to significantly slow down and even reverse the shortening of our telomeres, the caps on the end of our chromosomes that shorten as we age.

Introducing One Truth 818

One Truth 818 anti-aging skin serum is formulated in New Zealand using the TAM-818 molecule as its active ingredient. Clinical trials on 100 volunteers at the renowned Abich Scientific Laboratories in Italy showed the most dramatic improvements in skin texture, firmness and elasticity ever discovered by the scientists who have tested many hundreds of other skin products.

That clinical testing was backed up by a series of tests on volunteers in New Zealand over a period of two months. Just like the Abich Labs tests in Italy, the New Zealand trials produced remarkable results. Abich Labs also tested One Truth serum for toxicity and adverse reactions. It found One Truth 818 produced zero adverse reactions.

More about TELOMERES

There is one primary reason why One Truth 818 anti-aging serum is so effective at real anti-aging. It all comes down to telomeres, the ‘caps’ on the end of our chromosomes. A telomere is like the little plastic tips on the end of a shoelace. As our cells divide, our telomeres get shorter and shorter. Eventually, our chromosomes can no longer replicate themselves. And we die. However, the human body can produce an enzyme called Telomerase, the miraculous enzyme that can slow down and even completely stop the shortening of our telomeres. But it needs help to be activated. That’s where TAM-818 comes in. TAM-818 is the strongest Telomerase-Inducing Molecule so far discovered by science. And One Truth 818 is the only skin serum in the world to contain TAM-818.

For more information, actual customer testimonials with before-and-after photos, and a complete list of One Truth 818 ingredients visit their website. http://www.OneTruthUSAMiracle.com.

Sherry Moxley Seaman
One Truth USA
(706) 833-0123
email us here

Rachael D’Aguiar shares the One Truth 818 story on how it came to be.

Source: EIN Presswire

Backed by 2 clusters and 45 innovative companies, the project will gear the French precision medicine industry toward new diagnostic and therapeutic approaches

PARIS, FRANCE, September 18, 2018 /EINPresswire.com/ — Medicen Paris Region and Cap Digital, two competitiveness clusters from the Greater Paris region, today announce that they are rallying their members to support the Hu-PreciMED project (Human Precision MEDicine) in order to structure the precision medicine industry in France. The project was jointly launched by Oncodesign, Servier and Intersystems. With more than 45 innovative digital and medical companies already participating, Hu-PreciMED aims to bring together all public and private players working in the field of precision medicine and connect them efficiently to medical data from patients. This is important in order to improve available therapeutic and diagnostic tools, as well as to develop new predictive and preventive medical approaches; all the while building on the latest progress in Big Data and Artificial Intelligence.

Precision medicine relies on the analysis of molecular and genetic characteristics to allow individualized or personalized treatment and monitoring of patients. It is a booming global market, expected to reach $96 billion by 2024 . This area of research is seen as key for the pharmaceutical industry to develop new therapeutic solutions and for patient care. Other criteria for organizations involved in this flourishing market include anticipating scientific, technological, regulatory, economic, ethical and digital developments. The precision medicine industry also requires support for patient data generation and easy access to this data.

The project consists of three main areas, each led by one of the three coordinators. Intersystems will focus on "target resolution", using patient data to identify subgroups in order to adapt treatments or discover new therapeutic targets. Servier will take care of "investigating new molecules", new therapeutic targets making it possible to identify biomarkers and to create and produce new compounds. Oncodesign will lead the third area with preclinical and clinical development of new drugs associated with biomarkers. To accomplish this project, two digital platforms will be set up, one for the integration of multi-source data and the other for data analysis.

The 45 public and private organizations already working on the project include the Paris Hospitals (AP-HP), the Transimmunom and Inflamex Laboratories of Excellence (LabEx), the Lille University Hospital and the Frédéric-Joliot Institute for Life Sciences – CEA.

While all therapeutic areas will be addressed, the pilot phase will focus on immuno-inflammatory diseases, which affect 5-7 per cent of the Western population and for which cohorts of referenced patients already exist or can be generated. The goal will be to identify the most relevant targets and to provide guidance for new drug development.

The project has a total of four phases and will run until 2023. The first phase runs until January 2019 and will focus on the design and development of the project. Between 2019 and 2020, the coordinators plan to develop and organize the industrial sector, before moving to a consolidation phase between 2020 and 2023, with more emphasis on business development. The final phase will run in 2022 and 2023, aimed at widening the range of addressed pathologies as well as geographical reach through international partnerships. The project was initially funded by the three industrial coordinators. Plans for further funding will aim primarily at the European level.

"The Hu-PreciMED project has taken shape thanks to the Medicen and Cap Digital clusters, which are deeply rooted in the French technology ecosystem, and have served as neutral and trustworthy third parties. They will continue to have a pivotal role in coordinating the collaborations and giving the project members access to their networks and their work methodology," said Philippe Genne, CEO of Oncodesign and vice president of the Medicen SME body, speaking on behalf of the three companies driving the project. "The call for interest was initiated last July, following the preview of the "Health Data Hub" project launched by French Health Minister Agnès Buzyn in June 2018. It showed that French organizations from this sector are very interested in this approach. By joining forces, we will be able to reach a critical mass and rely on French scientific excellence to shine internationally."

About Medicen Paris Region
Medicen Paris Region is a competitiveness cluster for innovative health technologies, with national and international scope. With more than 400 companies, research centers, universities, hospitals and local authorities as members, it aims to position the Paris region as Europe’s leading healthcare cluster. It focuses on five strategic areas: biological diagnostics, diagnostic and interventional imaging, regenerative medicine and biomaterials, digital health and translational medicine. In close collaboration with local, regional and national healthcare innovation players, Medicen Paris Region aims to:
• Foster the emergence, development and funding of certified collaborative projects in the healthcare sector, in order to create economic value and jobs
• Increase the international development of innovative startups and SMEs
• Strengthen the attractiveness of the Paris region, which represents more than 50% of life sciences activity in France
Since the creation of the cluster in 2005, 68 innovative products have been launched in the imaging, medical devices and biological tools sectors. The cluster has certified 302 projects. They received funding from the French government (French Inter-Ministry Fund FUI, Structuring Projects fund), the public investment bank Bpifrance, the National Research Agency, the European Regional Development Fund, the Investments for the Future program and/or local authorities, and the Paris region. Total investment is close to €1.9 billion ($2.3bn) and €533 million ($635M) of public aid.
www.medicen.org

Juliette Dos Santos
Andrew Lloyd & Associates
33 1 56 54 07 00
email us here

Source: EIN Presswire